Skip to content

Cyberknife Radiosurgery and Quality of Life

Cyberknife Radiosurgery and Quality of Life

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01163539
Enrollment
15
Registered
2010-07-15
Start date
2010-07-31
Completion date
2012-06-30
Last updated
2016-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Cancer, Central Nervous System Cancer

Brief summary

The purpose of this study is to look at pain control and QOL improvement after treatment with CK Radiosurgery for spinal metastases.

Interventions

None listed

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with a spinal metastasis who will be treated with Cyberknife radiosurgery. * There are no age or gender restrictions. * There are no life expectancy restrictions. * Karnofsky Performance Status greater than 40. * Negative pregnancy test or clinically assessed as not pregnant. * Ability to understand and the willingness to sign a written informed consent document.

Exclusion criteria

* Patients with benign tumors will not be included (neurofibromas, schwannomas, etc.) * Other investigational medications or treatments will be noted, but will not preclude inclusion. * Pregnant or nursing patients will be not be included in the study due to radiation exposure.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026